Effectiveness of a Targeted Agent in Soft-Tissue Sarcoma


According to a recent study, treatment with the multikinase inhibitor entrectinib produces durable responses in all of the following soft-tissue sarcomas EXCEPT:


A. Endometrial stromal sarcoma

B. Epithelioid sarcoma

C. Uterine leiomyosarcoma


To see the correct answer, click here.


Related Content

Comparative Effectiveness Study Reveals Optimal Treatment for Soft-Tissue Sarcoma

Improved Survival from Neoadjuvant Chemotherapy for Soft-Tissue Sarcoma